Gå direkt till huvudinnehållet

Refluxsymtom

Senast reviderad:
Sakkunnig:
  1. Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):325-37. doi: 10.1016/j.bpg.2013.06.008. PMID: 23998972 PubMed  
  2. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agréus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005 Mar;40(3):275-85. doi: 10.1080/00365520510011579. PMID: 15932168 PubMed  
  3. Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1998; 33:1127-33. PubMed  
  4. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920. PubMed  
  5. Chassany O, Shaheen NJ, Karlsson M, et al. Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia. Scand J Gastroenterol. 2012;47:1412-1421. PubMed  
  6. Flook N, Unge P, Agreus L, et al. Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause? Can Fam Physician 2007;53:261-266. PubMed  
  7. Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain. A meta-analysis. Arch Intern Med 2005; 165: 1222-28. PubMed  
  8. Sigterman KE, Pinxteren B van, Bonis PA, Lau J, Numans ME. Short term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database of Systematic Reviews : Issue 6 of 12, June 2013, CD002095.pub5. PMID: 23728637 PubMed  
  9. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease?: an evidence-based approach. Arch Intern Med 2006; 166: 965-71. PMID: 16682569 PubMed  
  10. Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016 Feb;14(2):175-82.e1-3. doi: 10.1016/j.cgh.2015.04.176. Epub 2015 May 6. PMID: 2595683 PubMed  
  11. Hallan A, Bomme M, Hveem K, Møller-Hansen J, Ness-Jensen E. Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study. Am J Gastroenterol. 2015 Mar;110(3):393-400; quiz 401. doi: 10.1038/ajg.2015.18. Epub 2015 Feb 10. PMID: 25665934 PubMed  
  • Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet
  • Terje Johannessen, professor i allmennmedisin, Trondheim